Gene · 2829
NIH grants1,173
NIH grants whose papers are about the gene, through NIH's grant-paper links.
521 to 540 of 1,173
Download this page as JSON| Grant | Title | XCR1 papers | Newest fiscal year |
|---|---|---|---|
| R01DK108434 | Barrier integrity, microbiome and HIV target cell interactions in the human male genital tract pre and post circumcision | 1 | 2022 |
| R01DK118731 | Hepatokine Regulation of Thermogenesis and Metabolic Physiology | 1 | 2022 |
| R01ES029280 | Environmental Exposures, AHR Activation, and Placental Origins of Development | 1 | 2022 |
| R01GM071966 | lntegration and Visualization of Diverse Biological Data | 1 | 2022 |
| R01HL056067 | T-Cell Targeting for GVHD | 1 | 2022 |
| R01HL103827 | Targeting Notch2 in Hematopoietic Cell Therapy. | 1 | 2022 |
| R01HL141137 | Complement-Induced Endothelial Cell Activation by a Novel Rab5-ZFYVE21-SMURF2 Signaling Axis | 1 | 2022 |
| R01HL141966 | Role of E3 Ubiquitin ligase RNF133 in T cell function and tolerance | 1 | 2022 |
| R01HL144620 | Red blood cell released ATP in disturbed blood flow-initiated site specific vascular inflammation and atherosclerosis | 1 | 2022 |
| R01HL147662 | Novel Molecular Target to Prevent Maturation Failure of Arteriovenous Fistula | 1 | 2022 |
| R01HL148094 | Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV | 1 | 2022 |
| R21AI163775 | Novel transcription factors modulating the development and function of pDCs and pDC-related cells | 1 | 2022 |
| R21NS128551 | Lymphangiogenesis in chronic brain infection | 1 | 2022 |
| R35CA197603 | HARNESSING HOST RESPONSE TO PREVENT MYELOMA | 1 | 2022 |
| R56AG068026 | Advancing drug repositioning and development for Alzheimer's Disease using functional genomics and computational phenomics | 1 | 2022 |
| T32GM107000 | Medical Scientist Training at UMMS | 1 | 2022 |
| T32HL116270 | Training Program in Cardiovascular Applied Research and Entrepreneurship | 1 | 2022 |
| U01AI140498 | T Cell Reagent Research for Monitoring T Cell in Food Allergy | 1 | 2022 |
| U01CA233102 | Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies | 1 | 2022 |
| U01HG007690 | Center for Integrated Approached to Undiagnosed Diseases | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2829/grants?page=27